Search

everythinglearnresearchcommunity

for

Search:↓

Nails can reveal important health information about skin and body conditions.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Etretinate has only moderate effects on localized scleroderma and lichen sclerosus.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Doctors should consider SLE in males even if antinuclear antibody tests are negative.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

SLE and DM can coexist but are rare and need careful evaluation.

The COVID-19 vaccine is viewed more negatively and causes more side effects than the flu vaccine in Korean patients with lupus.

Higher leptin levels link to hair loss.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Interferon beta treatment in MS patients can cause skin reactions and increased hair loss.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Systemic lupus erythematosus is diagnosed earlier in males than females.

Skin may help in getting rid of excess iron through the process of skin cell renewal.

Two patients had a rare combination of red skin spots and white scaly skin lesions not on the genitals.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Early diagnosis and treatment of calcinosis cutis in lupus patients is crucial due to its rarity and potential complications.